Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
All the vital news, analysis, and commentary curated by our industry experts.
Insulin Pumps and Continuous Glucose Monitors Market Report Overview
The insulin pumps and continuous glucose monitors market size was $10.57 billion in 2022. An insulin pump administers programmed doses of insulin for diabetes management and a continuous glucose monitoring system helps in the continuous measurement of blood glucose.
Insulin Pumps and Continuous Glucose Monitors Market Outlook, 2022-2033 ($ Billion)
Buy Full Report for More Insights into the Insulin Pumps and Continuous Glucose Monitors Market Forecast
The Insulin Pumps and Continuous Glucose Monitors market research report is built to visualize quantitative market trends within the Diabetes Care Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Insulin Pumps and Continuous Glucose Monitors market for the year 2020 and beyond. Each of the covered 39 countries’ color-coded and fully sourced market models are equipped with epidemiology-based indications with procedure volumes.
|Market Size (2022)||$10.57 billion|
|Key Segments||· Insulin Pumps
· Blood Glucose Meters
|Key Regions||· North America
· Asia Pacific
· South America
· Middle East and Africa
|Leading Companies||· Medtronic Plc
· Abbott Laboratories
· DexCom Inc
· Senseonics Inc
· Insulet Corp
· F. Hoffmann-La Roche Ltd
· Ypsomed Holding AG
· Tandem Diabetes Care Inc
· MannKind Corp
|Enquire & Decide||Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.|
Insulin Pumps and Continuous Glucose Monitors Market Dynamics
The Diabetes Care Devices (DCD) market has witnessed massive demand over the past few years due to the increase in the prevalence number of people suffering from diabetes and a growing awareness among consumers regarding the availability of new technological advancements in the market. The major growth driver of the DCD market is the increase in incidence and prevalence of diabetes which is the result of a sedentary lifestyle, obesity, and imbalanced diet. The availability of reimbursement policies in developed countries also adds to the growing DCD market. Additionally, harmful effects associated with some of the diabetes care devices and the high cost of the devices hamper the market growth.
Insulin Pumps and Continuous Glucose Monitors Market Segments
The market can be segmented into insulin pumps and blood glucose meters. Insulin pumps led the market in 2022. They can be further segmented into traditional insulin pumps & accessories and patch pumps. Blood glucose meters can be sub-segmented into continuous glucose monitors and continuous glucose monitors – sensors.
Insulin Pumps and Continuous Glucose Monitors Market Analysis by Segments, 2022 (%)
Buy Full Report for More Segment Insights into the Insulin Pumps and Continuous Glucose Monitors Market
Insulin Pumps and Continuous Glucose Monitors Market Segmentation by Regions
The key regions in the insulin pumps and continuous glucose monitors market are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America dominated the market in 2022. The US holds a dominating position in this regional market following Canada and Mexico. The market is majorly driven by the increasing prevalence rate of diabetes, increase in the prevalence of obesity, sedentary lifestyle, increasing awareness among consumers, and rapid innovation and advancements in technologies.
Insulin Pumps and Continuous Glucose Monitors Market Analysis by Regions, 2022 (%)
Buy Full Report to Know More about the Regions in Insulin Pumps and Continuous Glucose Monitors Market
Insulin Pumps and Continuous Glucose Monitors Market - Competitive Landscape
Some of the leading companies in the insulin pumps and continuous glucose monitors market are Medtronic Plc, Abbott Laboratories, DexCom Inc, Senseonics Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and MannKind Corp. Medtronic Plc held the largest share of the insulin pumps and continuous glucose monitors market in 2022.
Insulin Pumps and Continuous Glucose Monitors Market Analysis by Companies, 2022 (%)
Buy Full Report to Know More about the Companies in the Insulin Pumps and Continuous Glucose Monitors Market
Segments Covered in the Report
Insulin Pumps and Continuous Glucose Monitors Segments Outlook (Value, $ Billion, 2015-2033)
- Insulin Pumps
- Traditional Insulin Pumps & Accessories
- Traditional Insulin Pump Accessories
- Traditional Insulin Pumps
- Patch Pumps
- Non-Programmable Insulin Patch Pumps
- Programmable Insulin Patch Pumps – Pods
- Programmable Insulin Patch Pumps
- Blood Glucose Meters
- Continuous Glucose Monitors
- Continuous Glucose Monitors – Sensors
- Traditional Insulin Pumps & Accessories
Insulin Pumps and Continuous Glucose Monitors Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Asia Pacific
- South America
- Middle East and Africa
Key Inclusions of the market model are:
Currently marketed Insulin Pumps and Continuous Glucose Monitors and evolving competitive landscape –
– Insightful review of the key industry trends.
– Annualized total Insulin Pumps and Continuous Glucose Monitors market revenue by segment and market outlooks from 2015-2033.
– Granular data on total procedures, units, average selling prices, and market values by segment.
Global, Regional, and Country level market specific insights –
– Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
– SWOT analysis for the Insulin Pumps and Continuous Glucose Monitors market.
– Competitive dynamics insights and trends provided for the Insulin Pumps and Continuous Glucose Monitors market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the market access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country-specific overview of the healthcare system.
– Country-specific reimbursement policies.
– Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered – Medtronic Plc, DexCom Inc, Abbott Laboratories, Senseonics Inc, Ypsomed Holding AG, Tandem Diabetes Care Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, MannKind Corp, and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have a deep understanding of the Insulin Pumps and Continuous Glucose Monitors marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the insulin pumps and continuous glucose monitors market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the insulin pumps and continuous glucose monitors market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the insulin pumps and continuous glucose monitors market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific insulin pumps and continuous glucose monitors market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
F. Hoffmann-La Roche Ltd
Ypsomed Holding AG
Tandem Diabetes Care Inc
Frequently asked questions
What was the insulin pumps and continuous glucose monitors market size in 2022?
The insulin pumps and continuous glucose monitors market size was $10.57 billion in 2022.
Which region held the largest share of the insulin pumps and continuous glucose monitors market?
North America held the largest insulin pumps and continuous glucose monitors market share in 2022.
Which segment held the largest share of the insulin pumps and continuous glucose monitors market?
Insulin pumps led the insulin pumps and continuous glucose monitors market in 2022.
Who are the major players operating in the insulin pumps and continuous glucose monitors market?
Some of the leading companies in the insulin pumps and continuous glucose monitors market are Medtronic Plc, Abbott Laboratories, DexCom Inc, Senseonics Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and MannKind Corp.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.